SOPHiA GENETICS to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) announced its participation in the Morgan Stanley 19th Annual Global Healthcare Conference on September 10, 2021. The presentation is scheduled for 9:30 a.m. Eastern Time/3:30 p.m. Central European Time and will be accessible via a live and archived webcast on the company’s website.

The company is a leader in data-driven medicine and offers the SOPHiA DDM™ Platform, which supports over 780 institutions globally in analyzing complex data sets for healthcare and life sciences.

BOSTON and LAUSANNE, Switzerland, Aug. 30, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference.

SOPHiA GENETICS’ management is scheduled to present on Friday, September 10^th at 9:30 a.m. Eastern Time/3:30 p.m. Central European Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: ir.sophiagenetics.com.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally.

Availability of Other Information About SOPHiA GENETICS:

Investors and others should note that SOPHiA GENETICS communicates with its investors and the public using its company website (SOPHiAGENETICS.COM) as well as other channels, including but not limited to U.S. Securities and Exchange Commission filings, press releases, presentations, public conference calls and webcasts. The information SOPHiA GENETICS communicates through these channels could be deemed to be material information. As a result, SOPHiA GENETICS encourages investors and others interested in SOPHiA GENETICS to review the information it disseminates through these channels on a regular basis.

Investor Contact:
Carrie Mendivil
carrie@gilmartinir.com

Media Contact:
sophiagenetics@consortpartners.com

FAQ

When will SOPHiA GENETICS present at the Morgan Stanley Global Healthcare Conference?

SOPHiA GENETICS is scheduled to present on September 10, 2021, at 9:30 a.m. Eastern Time.

How can I access the SOPHiA GENETICS conference presentation?

The presentation can be accessed through a live and archived webcast on the Investors section of the company’s website.

What is the SOPHiA DDM™ Platform?

The SOPHiA DDM™ Platform is a cloud-based SaaS platform that analyzes complex multimodal data sets for healthcare and life sciences research.

How many institutions use SOPHiA GENETICS solutions?

SOPHiA GENETICS solutions are currently utilized by more than 780 hospitals, laboratories, and biopharma institutions worldwide.

Where can I find additional information about SOPHiA GENETICS?

Additional information can be found on the company's website, as well as through SEC filings, press releases, and public conference calls.